Volunteer Julien Oppliger rests after receiving a new generation COVID-19 vaccine administered via an arm patch during a Phase I clinical study, led by Unisante at the University Hospital (CHUV) in Lausanne, Switzerland, January 19, 2022. REUTERS/Cecile Mantovani